News
SER
9.12
-2.87%
-0.27
Weekly Report: what happened at SER last week (0429-0503)?
Weekly Report · 3d ago
Serina Therapeutics files to sell 1.5M shares of common stock
Healthcare Serina Therapeutics files to sell 1.5M shares of common stock May 03, 2024 5:45 PM ETSerina Therapedutics, Inc. Filed a prospectus related to the offer and sale of 1.4 million shares of stock. This prospectus is not an offer to sell.
Seeking Alpha · 5d ago
Weekly Report: what happened at SER last week (0422-0426)?
Weekly Report · 04/29 11:09
Weekly Report: what happened at SER last week (0415-0419)?
Weekly Report · 04/22 10:59
Serina Therapeutics Names Simba Gill as Executive Chairman
Serina Therapeutics named Simba Gill as the company's new executive chairman. The biotechnology company is developing a pipeline of drug product candidates to treat neurological diseases and pain. Prior to Serina, Gill served in key roles at Maxygen, Systemix and Celltech.
Dow Jones · 04/17 20:30
SERINA THERAPEUTICS APPOINTS DR. SIMBA GILL AS EXECUTIVE CHAIRMAN
Reuters · 04/17 20:05
Weekly Report: what happened at SER last week (0408-0412)?
Weekly Report · 04/15 10:52
Weekly Report: what happened at SER last week (0401-0405)?
Weekly Report · 04/08 10:56
Serina Therapeutics: General statement of acquisition of beneficial ownership
Press release · 04/04 01:28
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
MSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday's pre-market session. Serina Therapeutics (AMEX:SER) stock moved upwards by 28.33%. CareMax (NASdaq:CMAX) and Imunon stock rose by 18.49% and 16.58% respectively. Losers Acorda Therapeutic and Gritstone Bio lost 75.1% of their value.
Benzinga · 04/02 12:07
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
XTI Aerospace (NASDAQ:XTIA) stock is rocketing more than 94% alongside heavy pre-market trading. Merger agreements, earnings reports, and a major spinoff are worth watching on Tuesday morning. The biggest pre- market stock movers include XTI Aerospace, Kidpik and MSP Recovery.
Investorplace · 04/02 11:38
Serina Therapeutics: Strategic Restructuring and Merger Success
TipRanks · 04/01 21:42
Weekly Report: what happened at SER last week (0325-0329)?
Weekly Report · 04/01 10:54
*News On AgeX Therapeutics Inc. (AGE) Now Under SER
Dow Jones · 03/27 21:08
Weekly Report: what happened at AGE last week (0318-0322)?
Weekly Report · 03/25 10:57
AgeX Therapeutics GAAP EPS of -$13.73
Seeking Alpha · 03/25 04:59
Weekly Report: what happened at AGE last week (0311-0315)?
Weekly Report · 03/18 10:55
Agex Therapeutics: [Cover]SEC-generated letter
Press release · 03/15 23:02
Weekly Report: what happened at AGE last week (0304-0308)?
Weekly Report · 03/11 10:53
Weekly Report: what happened at AGE last week (0226-0301)?
Weekly Report · 03/04 10:55
More
Webull provides a variety of real-time SER stock news. You can receive the latest news about Serina Therapeutics through multiple platforms. This information may help you make smarter investment decisions.
About SER
Serina Therapeutics, Inc., formerly AgeX Therapeutics, Inc., is a clinical-stage biotechnology company. The Company is engaged in developing a pipeline of wholly owned drug product candidates to treat neurological diseases and pain. Its POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. Its POZ Platform partners are at the forefront in advancing LNP delivery technology to develop RNA therapeutics. The Company is focused on the advancement of its lead drug candidate, SER-252 (POZ-apomorphine), for the treatment of advanced Parkinson’s Disease through pre-clinical studies. The Company intends to advance SER 252 into Phase I clinical trials.